Connor Clark & Lunn Investment Management Ltd. has reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 41.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 230,365 shares of the company's stock after selling 163,654 shares during the quarter. As of the latest filing, Connor Clark & Lunn Investment Management Ltd. owned about 0.14% of Option Care Health, worth $8.05 million.\n\nSeveral other hedge funds also made changes to their positions. Compass Wealth Management LLC boosted its position by 8.9%, now owning 166,078 shares valued at $5.8 million. Bessemer Group Inc. increased its holdings by 62.3%, now owning 1,560 shares worth $54,000. Principal Financial Group Inc. boosted its holdings by 1.4%, now owning 485,871 shares worth $16.98 million. Wealth Enhancement Advisory Services LLC increased its position by 25.7%, now owning 8,274 shares worth $289,000. GAMMA Investing LLC boosted its holdings by 307.1%, now owning 3,192 shares worth $112,000.\n\nAs of now, 98.05% of the company's stock is held by institutional investors and hedge funds.\n\nOption Care Health reported a 15.4% year-over-year increase in quarterly revenue, reaching $1.42 billion, with earnings per share of $0.41, exceeding analysts' estimates of $0.40. The company's net margin was 3.93%, return on equity was 17.53%, and revenue grew 15.4% compared to the same quarter last year. The company's 52-week high is $35.53, and the 52-week low is $21.39. The stock currently trades at $28.53, with a market cap of $4.63 billion, a price-to-earnings ratio of 22.82, a PEG ratio of 1.80, and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00, and a current ratio of 1.52.\n\nResearch analysts have issued various ratings on the stock. Barrington Research reissued an 'outperform' rating with a $38.00 target price. JMP Securities raised their target price to $38.00 and gave a 'market outperform' rating. UBS Group upgraded the rating to 'buy' and increased the target price to $40.00. Citigroup reissued an 'outperform' rating. Overall, one analyst has a 'hold' rating and eight have a 'buy' rating, resulting in a consensus rating of 'Moderate Buy' and a consensus target price of $35.75.\n\nOption Care Health provides home and alternate site infusion services in the United States, including anti-infective therapies, home infusion for heart failure, parenteral and enteral nutrition support for chronic conditions, immunoglobulin therapy for immune deficiencies, and treatments for chronic inflammatory disorders such as Crohn's disease, psoriasis, and rheumatoid arthritis.

Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. reduced its stake in Option Care Health, Inc. by 41.5% in the first quarter, selling 163,654 shares and now holding 230,365 shares worth $8.05 million, representing 0.14% of the company's total shares. Other hedge funds such as Compass Wealth Management LLC, Bessemer Group Inc., Principal Financial Group Inc., Wealth Enhancement Advisory Services LLC, and GAMMA Investing LLC adjusted their positions, with some increasing holdings significantly. Option Care Health reported a 15.4% year-over-year revenue increase to $1.42 billion, with earnings per share of $0.41 and a net margin of 3.93%. The company's stock trades at $28.53 with a market cap of $4.63 billion. Analysts have issued various ratings, with a consensus 'Moderate Buy' and target price of $35.75. The company offers home and alternate site infusion services in the United States for chronic conditions including heart failure, Crohn's disease, psoriasis, and rheumatoid arthritis.